• Most Popular
  • Most Shared

AstraZeneca sees reduced share buyback in 2008

LONDON
Mon Apr 23, 2007 11:06am EDT

Stocks

   

LONDON (Reuters) - AstraZeneca Plc (AZN.L) will reduce its share buyback program in 2008 from the $4 billion level planned in 2007, following the acquisition of U.S. biotech firm MedImmune Inc. MEDI.O.

Asian Markets  |  Mergers & Acquisitions

Chief Financial Officer Jon Symonds said the all-cash $15.2 billion deal would increase balance-sheet leverage and management would take a pragmatic approach to further buybacks, given possible opportunities for other smaller acquisitions.

"The board will want to make sure that we maintain capacity for opportunities in future," he told reporters in a conference call on Monday.

"I don't think it (the 2008 buyback) will be at 2007 levels but I don't think it will be zero."
Asian Markets
Mergers & Acquisitions


More from Reuters

Photo

Bomber, U.S. drone attack in Pakistan

ISLAMABAD (Reuters) - A suicide bomber killed up to 10 people in Pakistan Friday, while a suspected U.S. drone killed six militants, as rising political tension threatened to distract the government from its war against the Taliban.

» More Top News
U.S. President Barack Obama attends the morning plenery session of the United Nations Climate Change Conference (COP15) at the Bella Center in Copenhagen, Denmark, December 18, 2009. REUTERS/Larry Downing

Time running out on climate

President Barack Obama met world leaders in Copenhagen in a bid to reach a new global climate agreement after all-night talks failed.   Full Article | Video 

Climate conference
Pedestrians are reflected in a Citigroup window in Boston, Massachusetts. REUTERS/Brian Snyder

Citi's next challenge

Citigroup's plan to extract itself from the government's clutches didn't go as planned. For the bank to succeed, one of two things need to happen.  Full Article 

ECONOMY